Consolidated income statements - USD ($)
shares in Millions, $ in Millions |
3 Months Ended |
6 Months Ended |
Jun. 30, 2020 |
Jun. 30, 2019 |
Jun. 30, 2020 |
Jun. 30, 2019 |
| Statement [line items] |
|
|
|
|
|
| Net sales to third parties from continuing operations |
|
$ 11,347
|
$ 11,764
|
$ 23,630
|
$ 22,870
|
| Sales to discontinued operations |
|
|
|
|
53
|
| Net sales from continuing operations |
|
11,347
|
11,764
|
23,630
|
22,923
|
| Other revenues |
|
275
|
260
|
700
|
556
|
| Cost of goods sold |
|
(3,429)
|
(3,406)
|
(7,151)
|
(6,657)
|
| Gross profit from continuing operations |
|
8,193
|
8,618
|
17,179
|
16,822
|
| Selling, general and administration |
|
(3,368)
|
(3,585)
|
(6,854)
|
(6,915)
|
| Research and Development |
|
(2,441)
|
(2,051)
|
(4,501)
|
(4,350)
|
| Other income |
|
432
|
989
|
693
|
1,192
|
| Other expense |
|
(464)
|
(1,308)
|
(1,421)
|
(1,844)
|
| Operating income from continuing operations |
|
2,352
|
2,663
|
5,096
|
4,905
|
| Income from associated companies |
|
183
|
176
|
306
|
256
|
| Interest expense |
|
(220)
|
(205)
|
(459)
|
(431)
|
| Other financial income and expense |
|
(27)
|
0
|
(34)
|
44
|
| Income before taxes from continuing operations |
|
2,288
|
2,634
|
4,909
|
4,774
|
| Taxes |
|
(421)
|
(525)
|
(869)
|
(797)
|
| Net income from continuing operations |
|
1,867
|
2,109
|
4,040
|
3,977
|
| Net income/loss from discontinued operations before gain on distribution |
|
|
|
|
(101)
|
| Gain on distribution |
|
|
4,691
|
|
4,691
|
| Net income/loss from discontinued operations |
|
|
4,691
|
|
4,590
|
| Net income |
|
1,867
|
6,800
|
4,040
|
8,567
|
| Attributable to |
|
|
|
|
|
| Shareholders of Novartis AG |
|
1,867
|
6,799
|
4,043
|
8,565
|
| Non-controlling interests |
|
$ 0
|
$ 1
|
$ (3)
|
$ 2
|
| Basic earnings per share [abstract] |
|
|
|
|
|
| Weighted average number of shares outstanding used in the basic earnings per share |
|
2,289
|
2,310
|
2,281
|
2,312
|
| Basic earnings per share, Continuing operations |
[1] |
$ 0.82
|
$ 0.91
|
$ 1.77
|
$ 1.72
|
| Basic earnings per share, Discontinued operations |
[1] |
|
2.03
|
|
1.98
|
| Basic earnings per share |
[1] |
$ 0.82
|
$ 2.94
|
$ 1.77
|
$ 3.70
|
| Diluted earnings per share [abstract] |
|
|
|
|
|
| Weighted average number of shares in diluted earnings per share |
|
2,304
|
2,333
|
2,299
|
2,336
|
| Diluted earnings per share, Continuing operations |
[1] |
$ 0.81
|
$ 0.90
|
$ 1.76
|
$ 1.70
|
| Diluted earnings per share, Discontinued operations |
[1] |
|
2.01
|
|
1.96
|
| Diluted earnings per share |
[1] |
$ 0.81
|
$ 2.91
|
$ 1.76
|
$ 3.66
|
|
|